SKYE
Price:
$1.21
Market Cap:
$38.77M
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
Industry
Biotechnology
IPO Date
2014-11-26
Stock Exchange
NASDAQ
Ticker
SKYE
According to Skye Bioscience, Inc.’s latest financial reports and current stock price. The company's current ROE is -68.65%. This represents a change of 249.66% compared to the average of -19.63% of the last 4 quarters.
The mean historical ROE of Skye Bioscience, Inc. over the last ten years is 66.69%. The current -68.65% ROE has changed -202.93% with respect to the historical average. Over the past ten years (40 quarters), SKYE's ROE was at its highest in in the December 2019 quarter at 3.93%. The ROE was at its lowest in in the September 2023 quarter at -1471.52%.
Average
66.69%
Median
157.64%
Minimum
-1455.46%
Maximum
1.77%
Discovering the peaks and valleys of Skye Bioscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 172.65%
Maximum Annual ROE = 1.77%
Minimum Annual Increase = -858.25%
Minimum Annual ROE = -1455.46%
| Year | ROE | Change |
|---|---|---|
| 2024 | -38.98% | -102.21% |
| 2023 | 1.77% | 172.65% |
| 2022 | 647.66% | -545.67% |
| 2021 | -145.32% | -90.02% |
| 2020 | -1455.46% | -858.25% |
| 2019 | 191.95% | 55.63% |
| 2018 | 123.34% | -68.11% |
| 2017 | 386.71% | 76.55% |
| 2016 | 219.04% | -121.31% |
| 2015 | -1027.86% | -270.51% |
The current ROE of Skye Bioscience, Inc. (SKYE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
791.51%
5-year avg
154.75%
10-year avg
66.69%
Skye Bioscience, Inc.’s ROE is greater than Aligos Therapeutics, Inc. (-132.42%), greater than Xilio Therapeutics, Inc. (-618.98%), less than Mersana Therapeutics, Inc. (183.15%), greater than INmune Bio, Inc. (-172.00%), greater than X4 Pharmaceuticals, Inc. (-375.31%), greater than Kezar Life Sciences, Inc. (-63.52%), greater than Barinthus Biotherapeutics plc (-70.19%), greater than LAVA Therapeutics N.V. (-106.65%), greater than PDS Biotechnology Corporation (-1.47%), greater than CEL-SCI Corporation (-259.39%),
| Company | ROE | Market cap |
|---|---|---|
| -132.42% | $62.09M | |
| -618.98% | $38.90M | |
| 183.15% | $137.32M | |
| -172.00% | $49.98M | |
| -375.31% | $43.35M | |
| -63.52% | $45.77M | |
| -70.19% | $29.44M | |
| -106.65% | $45.77M | |
| -1.47% | $43.78M | |
| -259.39% | $43.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Skye Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Skye Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Skye Bioscience, Inc.'s ROE?
How is the ROE calculated for Skye Bioscience, Inc. (SKYE)?
What is the highest ROE for Skye Bioscience, Inc. (SKYE)?
What is the 3-year average ROE for Skye Bioscience, Inc. (SKYE)?
What is the 5-year average ROE for Skye Bioscience, Inc. (SKYE)?
How does the current ROE for Skye Bioscience, Inc. (SKYE) compare to its historical average?